U.S. markets closed
  • S&P Futures

    4,571.50
    +13.50 (+0.30%)
     
  • Dow Futures

    35,688.00
    +68.00 (+0.19%)
     
  • Nasdaq Futures

    15,571.00
    +75.25 (+0.49%)
     
  • Russell 2000 Futures

    2,318.40
    +8.10 (+0.35%)
     
  • Crude Oil

    83.62
    -0.14 (-0.17%)
     
  • Gold

    1,805.70
    -1.10 (-0.06%)
     
  • Silver

    24.54
    -0.05 (-0.21%)
     
  • EUR/USD

    1.1608
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.6350
    -0.0200 (-1.21%)
     
  • Vix

    15.24
    -0.19 (-1.23%)
     
  • GBP/USD

    1.3764
    -0.0004 (-0.03%)
     
  • USD/JPY

    113.8390
    +0.1400 (+0.12%)
     
  • BTC-USD

    62,774.41
    +1,058.33 (+1.71%)
     
  • CMC Crypto 200

    1,507.40
    +1,264.72 (+521.15%)
     
  • FTSE 100

    7,222.82
    +18.27 (+0.25%)
     
  • Nikkei 225

    29,104.53
    +504.12 (+1.76%)
     

Why Impel NeuroPharma Stock Is Soaring Today

·2 min read
Why Impel NeuroPharma Stock Is Soaring Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Impel NeuroPharma (NASDAQ: IMPL) are shooting higher in response to Food and Drug Administration approval of the company's first drug. On Friday morning, the FDA approved Trudhesa, a new nasal spray made with an old migraine drug called dihydroergotamine mesylate. This is an especially big deal for Impel NeuroPharma because previously the company didn't have any means of generating revenue.